Dr Reddys Laboratories (RDY) Cash from Discontinued Operations (2012 - 2016)
Dr Reddys Laboratories (RDY) posted quarterly Cash from Discontinued Operations of 5233000000.0 for Q4 2016, up 93.17% quarter-over-quarter from 2709000000.0 in Q3 2016.
Dr Reddys Laboratories (RDY) Cash from Discontinued Operations (2012 - 2016) Analysis & Trends
Dr Reddys Laboratories' Cash from Discontinued Operations history runs 3 years deep, the most recent figure standing at 5233000000.0 for Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.11 Bn | 7.46 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 5.23 Bn |
| Dec 31, 2016 | 5.23 Bn |
| Sep 30, 2016 | 2.71 Bn |
| Sep 30, 2016 | 2.71 Bn |
| Dec 31, 2013 | 6.05 Bn |
| Dec 31, 2013 | 6.05 Bn |
| Sep 30, 2013 | 836.00 Mn |
| Sep 30, 2013 | 836.00 Mn |
| Jun 30, 2013 | 4.49 Bn |
| Jun 30, 2013 | 4.49 Bn |
| Dec 31, 2012 | 3.53 Bn |
| Dec 31, 2012 | 3.53 Bn |
| Sep 30, 2012 | 3.33 Bn |
| Sep 30, 2012 | 3.33 Bn |
| Jun 30, 2012 | 3.89 Bn |
| Jun 30, 2012 | 3.89 Bn |